Overview

Pharmacogenomics of Antiplatelet Response

Status:
Completed

Trial end date:
2015-05-01

Target enrollment:

Participant gender:

Summary

This clinical trial will examine with effect of 2-week aspirin therapy on platelet gene expression in persons at high-risk of developing heart attacks due to family history of early-onset coronary artery disease

Phase:

Phase 4

Details

Lead Sponsor:

Johns Hopkins University

Treatments:

Aspirin